Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A new paradigm of genetic testing for hereditary breast/ovarian cancers.

Hong Kong medical journal = Xianggang yi xue za zhi - 1 Apr 2016

Kwong Ava, Chen J W, Shin Vivian Y

Abstract excerpt

INTRODUCTION: Genetic risk factors and family history play an important role in breast cancer development. This review aimed to summarise the current genetic testing approach to hereditary breast/ovarian cancer. METHODS: A systematic literature review was performed by searching the PubMed database. Publications available online until January 2015 that addressed issues related to hereditary breast/ovarian cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to CHEK2 gene
Share to PALB2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Genetic Testing

Share to Molecular Biology

Share to Ovarian Neoplasms

Share to Risk Factors

Source

Identifiers

PMID: 26980575
DOI: 10.12809/hkmj154634

Genes

BRCA1
BRCA2
ATM
CHEK2
PALB2
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A new paradigm of genetic testing for hereditary breast/ovarian cancers.PMID 26980575Read ↗

Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.Semantic proximity Read ↗

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Semantic proximity Read ↗

Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test Panel.Semantic proximity Read ↗

Multigene assessment of genetic risk for women for two or more breast cancers.Semantic proximity Read ↗

Genetic Predisposition to Breast and Ovarian Cancers: How Many and Which Genes to Test?Semantic proximity Read ↗

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working GroupSemantic proximity Read ↗

Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation.Semantic proximity Read ↗

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.Semantic proximity Read ↗

Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer.Semantic proximity Read ↗

Hereditary breast cancer: an update on risk assessment and genetic testing in 2015.Semantic proximity Read ↗

Genetic counseling, testing, and screening for breast and ovarian cancer: practical and social considerations.Semantic proximity Read ↗

Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.